Edenred stock: UBS raises target for Edenred stock to EUR 28.50

Published on 10/20/2026 at 15:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue was EUR 687.00 million in the second quarter. Edenred stock costs EUR 29.48 on October 20, 2026, minus 1.67 percent versus the Xetra close.

UBS target revision

UBS raised its Edenred target from EUR 19.00 to EUR 28.50 on October 16, 2026.
Edenred reported EUR 687.00 million in second-quarter revenue for 2026.
Edenred stock costs EUR 29.48 at Lang & Schwarz on October 20, 2026 at 3:03 p.m. CEST, 1.67 percent below the Xetra close of October 19, 2026, and 4.44 percent below its EUR 30.85 52-week high.
Edenred's price-to-earnings ratio was 13.95 as of October 20, 2026.

Edenred SE, FR0010908533, Illustration mit AI erstellt.

UBS raised its Edenred price target from EUR 19.00 to EUR 28.50 on October 16, 2026, while keeping a neutral rating, according to Boursorama. Edenred stock was trading at EUR 29.48 at Lang & Schwarz on October 20, 2026 at 3:03 p.m. CEST, down 1.67 percent versus the Xetra close of October 19, 2026 at EUR 29.98.

Revenue provides the operating anchor

Edenred reported EUR 687.00 million in second-quarter 2026 revenue, with growth of 10.60 percent, according to Ideal Investisseur. The same report said Edenred had raised its 2026 EBITDA outlook after its first-half results, with double-digit growth expected in Mobility and high single-digit growth in Employee Benefits.

Stock sits below the yearly high

The Lang & Schwarz price of EUR 29.48 stood EUR 1.37 below Edenred's 52-week high of EUR 30.85 and remained above the 52-week low of EUR 15.23. The distance to the high was 4.44 percent, calculated from the October 20, 2026 price and the quoted range. Trading volume was 93,299 shares in the latest structured quote.

What does the target mean for valuation?

The UBS target of EUR 28.50 was 3.32 percent below the Lang & Schwarz price, using the two euro figures on October 20, 2026. UBS cited regulatory uncertainty in Brazil and possible future pressure on merchant commissions as downside factors, while its base case included a 225-basis-point reduction in merchant fees, as reported by Boursorama.

Edenred's price-to-earnings ratio was 13.95 as of October 20, 2026, while market capitalization stood at EUR 7.0 billion. The group generated EUR 3.0 billion in revenue during fiscal year 2025, according to Edenred.

Next reporting date is October 21

Edenred is scheduled to publish third-quarter 2026 revenue on October 21, 2026, according to the company's investor calendar. That release will provide the next company-specific test for the revenue trajectory and the 2026 outlook.

Target and price point in tension

UBS's neutral stance places the revised target below the latest euro quotation, while Edenred's second-quarter revenue growth and full-year outlook remain the central operating figures. The upcoming revenue publication is therefore more important for judging the gap between the target and the share price than the historical 2025 numbers.

The further course of trading is shown by the continuously updated real-time quote of Edenred stock.